These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 8835572)

  • 1. Antinuclear antibodies in children with localized scleroderma.
    Rosenberg AM; Uziel Y; Krafchik BR; Hauta SA; Prokopchuk PA; Silverman ED; Laxer RM
    J Rheumatol; 1995 Dec; 22(12):2337-43. PubMed ID: 8835572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-DNA topoisomerase IIalpha autoantibodies in localized scleroderma.
    Hayakawa I; Hasegawa M; Takehara K; Sato S
    Arthritis Rheum; 2004 Jan; 50(1):227-32. PubMed ID: 14730620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunologic changes in linear scleroderma in children. Apropos of 11 cases].
    Fontan I; Taïeb A; Guillet G; Rommel A; Fontan D; Maleville J
    Ann Dermatol Venereol; 1988; 115(2):135-41. PubMed ID: 3293512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies in Parry-Romberg syndrome: a serologic study of 14 patients.
    Garcia-de la Torre I; Castello-Sendra J; Esgleyes-Ribot T; Martinez-Bonilla G; Guerrerosantos J; Fritzler MJ
    J Rheumatol; 1995 Jan; 22(1):73-7. PubMed ID: 7699686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The antinuclear antibody spectrum in circumscribed forms of scleroderma].
    do Vale E; Gerstmeier H; Meurer M; Krieg T; Braun-Falco O
    Dtsch Med Wochenschr; 1986 Dec; 111(50):1922-7. PubMed ID: 3536401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity of antinuclear antibodies in scleroderma-like chronic graft-versus-host disease: clinical correlation and histocompatibility locus antigen association.
    Bell SA; Faust H; Mittermüller J; Kolb HJ; Meurer M
    Br J Dermatol; 1996 May; 134(5):848-54. PubMed ID: 8736324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Presence of the antinuclear antibodies and antibodies to Borrelia burgdorferi among patients with morphea en plaque, deep linear scleroderma and atrophoderma Pasini-Pierini].
    Wojas-Pelc A; Wielowieyska-Szybińska D; Kiełtyka A
    Przegl Lek; 2002; 59(11):898-902. PubMed ID: 12715718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies to HMG-17 nucleosomal protein in patients with scleroderma.
    Vlachoyiannopoulos PG; Boumba VA; Tzioufas AG; Seferiadis C; Tsolas O; Moutsopoulos HM
    J Autoimmun; 1994 Apr; 7(2):193-201. PubMed ID: 8037838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Borrelia-associated early-onset morphea": a particular type of scleroderma in childhood and adolescence with high titer antinuclear antibodies? Results of a cohort analysis and presentation of three cases.
    Prinz JC; Kutasi Z; Weisenseel P; Pótó L; Battyáni Z; Ruzicka T
    J Am Acad Dermatol; 2009 Feb; 60(2):248-55. PubMed ID: 19022534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antinuclear and anti-single-stranded DNA antibodies in morphea and generalized morphea.
    Falanga V; Medsger TA; Reichlin M
    Arch Dermatol; 1987 Mar; 123(3):350-3. PubMed ID: 3545090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific anti-nuclear antibodies in systemic sclerosis patients with and without skin involvement: an extended methodological approach.
    Van Praet JT; Van Steendam K; Smith V; De Bruyne G; Mimori T; Bonroy C; Elewaut D; Deforce D; De Keyser F
    Rheumatology (Oxford); 2011 Jul; 50(7):1302-9. PubMed ID: 21330340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihistone antibodies in linear scleroderma variants.
    el-Azhary RA; Aponte CC; Nelson AM; Weaver AL; Homburger HA
    Int J Dermatol; 2006 Nov; 45(11):1296-9. PubMed ID: 17076709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigen specificity of antihistone antibodies in localized scleroderma.
    Sato S; Fujimoto M; Ihn H; Kikuchi K; Takehara K
    Arch Dermatol; 1994 Oct; 130(10):1273-7. PubMed ID: 7524451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies to purified nuclear proteins related to DNA metabolism during ageing and in SLE patients.
    Astaldi Ricotti GC; Pazzaglia M; Martelli AM; Cerino A; Bestagno M; Caprelli A; Riva S; Pedrini MA; Facchini A
    Immunology; 1987 Jul; 61(3):375-81. PubMed ID: 3497092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effective detection of non-antidouble-stranded DNA antinuclear antibody specificities in daily clinical practice.
    Vos PA; Bast EJ; Derksen RH
    Rheumatology (Oxford); 2006 May; 45(5):629-35. PubMed ID: 16368728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Juvenile linear scleroderma associated with serologic abnormalities.
    Woo TY; Rasmussen JE
    Arch Dermatol; 1985 Nov; 121(11):1403-5. PubMed ID: 3876808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and serological heterogeneity in patients with anticentromere antibodies.
    Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
    J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies against matrix metalloproteinase-1 in patients with localized scleroderma.
    Tomimura S; Ogawa F; Iwata Y; Komura K; Hara T; Muroi E; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Sato S
    J Dermatol Sci; 2008 Oct; 52(1):47-54. PubMed ID: 18565735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-th/to-positivity in a cohort of patients with idiopathic pulmonary fibrosis.
    Fischer A; Pfalzgraf FJ; Feghali-Bostwick CA; Wright TM; Curran-Everett D; West SG; Brown KK
    J Rheumatol; 2006 Aug; 33(8):1600-5. PubMed ID: 16783860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum autoantibodies and their clinical associations in patients with childhood- and adult-onset linear scleroderma. A single-center study.
    Arkachaisri T; Fertig N; Pino S; Medsger TA
    J Rheumatol; 2008 Dec; 35(12):2439-44. PubMed ID: 19004036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.